Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-26 @ 2:07 AM
Study NCT ID:
NCT00787605
Status:
COMPLETED
Last Update Posted:
2016-10-27
First Post:
2008-11-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-11
Start Date Type:
None
Primary Completion Date:
2010-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-05
First Submit QC Date:
None
Study First Post Date:
2008-11-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-12-20
Results First Submit QC Date:
None
Results First Post Date:
2011-05-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-20
Last Update Post Date:
2016-10-27
Last Update Post Date Type:
ESTIMATED